IPIRA Startups

IPIRA Startups

Synvivia, Inc.

Brief Description

Synvivia is a synthetic biology company that optimizes cell behavior for gene therapy manufacturing, providing a practical solution for genetically encoded biocontainment. The company is building genetically encoded biocontainment technologies that will enable the widespread use of synthetic biology outside of the laboratory.

The company's technology was developed at UC Berkeley with grants from the NSF and DARPA. The work was published in ACS Synthetic Biology and featured as an Editor’s Choice in Science Magazine. Synvivia has exclusive license to the...

Sunesis Pharmaceuticals Inc.

Brief Description

Sunesis is a biopharmaceutical company focused on the development and future commercialization of new oncology therapeutics for the treatment of hematologic and solid tumor cancers. Sunesis has built an experienced cancer drug development organization committed to improving the lives of people with cancer. The company is focused on advancing its novel kinase-inhibitor pipeline, with an emphasis on establishing proof of concept that it's oral non-covalent BTK inhibitor, vecabrutinib (SNS-062), is effective in the treatment of ibrutinib-resistant chronic lymphocytic...

Silicor Materials, Inc.

Brief Description

Silicor Materials was a global leader in the production of solar silicon. The company was headquartered San Jose, California, with a research and development team located in Berlin, Germany.

The organization was founded as a development company in 2006 under the name Calisolar, with the goal of manufacturing low-cost photovoltaic (PV) solar cells from silicon designed specifically for the solar industry (“solar silicon”) rather than electronic-grade polysilicon. Among the company's founding members was solar energy pioneer UC Berkeley Professor of Materials Science...

Silicon Genesis Corporation

Brief Description

Silicon Genesis Corporation, doing business as SiGen, develops substrate technology, processes, and equipment for semiconductor, solar, display, and optoelectronics markets worldwide. The company provides silicon-on-insulators (SOIs), strained-silicon products, and other engineered multi-layer structures for microelectronic and photonics industries for advanced electronic and optoelectronic device applications. Its products include Stand-Alone Plasma-Activation Tool, a small footprint tool that provides a reactive surface to bond silicon wafers and heterogeneous...

Artris Therapeutics, Inc.

Brief Description

Artris Therapeutics was founded to identify and develop cancer therapeutics. The company was co-founded by UC Berkeley Professor of Chemical Biology and Molecular Therapeutics Daniel Nomura.

Timeline

2017. Company founded Inventors

Leslie Bateman, Jessica Cestellos Spradlin, Tucker Huffman, David Miyamoto, Elizabeth Anne Moore, Truc Bang Nguyen, Daniel Nomura, James Arthur Olzmann, Allison Marie Roberts, Carl Ward

ArKal Medical Inc.

Brief Description

ArKal Medical has developed the next generation continuous glucose monitoring system, using its minimally invasive, proprietary and patented MicroTipª technology. The Microtipsª provide painless access to ISF glucose. The ArKal CGM sensor is worn externally on the skin like a patch and measures glucose using classical electrochemical glucose oxidase enzyme-based chemistry. The GlucoPodª CGM system consists of three main components: a disposable sensor patch, a reusable transmitter, and a reusable wireless smart receiver.

Timeline 2004. Company founded...

Algen Biotechnologies

Brief Description

Algen Biotechnologies is building a next-generation, functional genomics-based platform for the discovery of novel therapeutics for cancers with high unmet need. Algen’s research group focuses on developing and applying novel functional genomics technologies to address scientific challenges in drug discovery. The company's biologists and data scientists are collaborating to deliver innovative, patient-centric medicines for the toughest-to-treat diseases.

The company was founded to commercialize technology developed at UC Berkeley while Algen Biotechnologies CEO...

Ambi Robotics

Brief Description

Ambi Robotics offers advanced robot grasping software for logistics and warehouse order fulfillment, allowing robots to grasp a wide variety of objects.

Ambi Robotics grew from the Dexterity Network (Dex-Net) project at UC Berkeley and is led by Dr. Jeff Mahler and Professor Ken Goldberg, experts in robot grasping with a combined 50+ years of experience.

Formerly known as Ambidextrous.

Timeline 2018. Company founded Inventors

Ken Goldberg, Jeffrey Mahler, Matthew Matl

Aguru Images, Inc.

Brief Description

Aguru Images, Inc. develops and markets image capture devices. It provides Dome, a spherical imaging device that is used for capturing the shape and reflectance properties of the human face to create computer generated digital doubles; Scope, a compact device that captures reflectance data for materials; and Scanner, which creates various photographs of an object moving lights across the image. The company's products are used in visual effects, animation, films, games, and multimedia and design industries. Aguru Images, Inc. was founded in 2006 and is based in Rockville,...

Ansa Biotechnologies

Brief Description

With synthetic DNA fueling innovation in biological research, therapeutics, diagnostics, and biomanufacturing, there is an urgent need for faster and more accurate DNA synthesis. Currently, DNA is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a faster, more accurate, and cleaner enzyme-based DNA synthesis technology. The technique promises to dramatically accelerate innovation in biological research and engineering.

The approach is based on polymerase-...